| Literature DB >> 7963413 |
J Lamoril1, F Lunel, P Laurent-Puig, C Defer, P Loiseau, J J Lefrère, J M Pawlotsky, P Marcellin, F Bouchardeau, M Bogard.
Abstract
Third-generation recombinant immunoblot assay is widely used for the validation of the serological diagnosis of hepatitis C virus infection. To determine whether indeterminate recombinant immunoblot assay 3.0 patterns may be associated with viral replication and liver disease, 89 indeterminate patterns were studied (67 c22n 14 c33c, 5 c100p and 3 NS5); 35 (39%) had immunosuppression. Serum alanine aminotransferase activity was increased in 49 (55%); HCV RNA was evidenced through polymerase chain reaction in 52 (58%). The observation of indeterminate recombinant immunoblot assay 3.0 justifies investigation of liver disease and search for HCV RNA, since a large proportion of individuals with such patterns are hepatitis C virus-infected.Entities:
Mesh:
Substances:
Year: 1994 PMID: 7963413 DOI: 10.1016/s0168-8278(94)80150-9
Source DB: PubMed Journal: J Hepatol ISSN: 0168-8278 Impact factor: 25.083